SiBone Retained Earnings (Accumulated Deficit) 2017-2024 | SIBN

SiBone retained earnings (accumulated deficit) from 2017 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.

SiBone Retained Earnings (Accumulated Deficit) 2017-2024 | SIBN

SiBone retained earnings (accumulated deficit) from 2017 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$197.4B
Intuitive Surgical (ISRG)$196.1B
Alcon (ALC)$42.2B
Edwards Lifesciences (EW)$41.5B
IQVIA Holdings (IQV)$35.9B
IDEXX Laboratories (IDXX)$34.3B
DexCom (DXCM)$29.1B
Waters (WAT)$21.9B
STERIS (STE)$21.3B
SONOVA HOLDING (SONVY)$20.5B
Hologic (HOLX)$18.3B
Fresenius Medical Care AG KGaA (FMS)$12.9B
Sysmex ADR (SSMXY)$12.8B
Globus Medical (GMED)$11.6B
Penumbra (PEN)$9.2B
Masimo (MASI)$9.1B
Teleflex (TFX)$8.9B
Glaukos (GKOS)$7.8B
PROCEPT BioRobotics (PRCT)$4.9B
Integer Holdings (ITGR)$4.6B
Veracyte (VCYT)$3B
Inari Medical (NARI)$2.9B
LivaNova (LIVN)$2.8B
TransMedics (TMDX)$2.7B
Nihon Kohden (NHNKY)$2.4B
Elekta AB (EKTAY)$2.1B
Tandem Diabetes Care (TNDM)$2B
RxSight (RXST)$1.8B
Integra LifeSciences Holdings (IART)$1.8B
Alphatec Holdings (ATEC)$1.4B